Taysha Gene Therapies, Inc. TSHA Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s other noncash income (expense)?
- Taysha Gene Therapies, Inc. (TSHA) reported other noncash income (expense) of -$27K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s other noncash income (expense) changed year-over-year?
- Taysha Gene Therapies, Inc.'s other noncash income (expense) decreased by 640.0% year-over-year, from $5K to -$27K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s other noncash income (expense)?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s other noncash income (expense) has grown at a -31.1% compound annual growth rate (CAGR), from -$906K to -$296K.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.